[1] Inflammatory and coagulation biomarkers and mortality in patients with HIV infection

[2] Childhood malaria in a region of unstable transmission and high human immunodeficiency virus prevalence

[3] Late Presentation With HIV in Africa: Phenotypes, Risk, and Risk Stratification in the REALITY Trial

[4] Mortality in patients with HIV-1 infection starting antiretroviral therapy in South Africa, Europe, or North America: a collaborative analysis of prospective studies

[5] Immune responses to measles and tetanus vaccines among Kenyan human immunodeficiency virus type 1 (HIV-1)-infected children pre- and post-highly active antiretroviral therapy and revaccination

[6] Use of total lymphocyte count for monitoring response to antiretroviral therapy

[7] Lymphocyte phenotyping in infants: maturation of lymphocyte subpopulations and the effects of HIV infection

[8] Induction of specific T-cell responses in HIV infection

[9] Exacerbation of skin mycobacterial lesions under highly active antiretroviral therapy in an HIV-infected patient

[10] The changing spectrum of the cutaneous manifestations of HIV disease

[11] Invasive bacterial and fungal infections among hospitalized HIV-infected and HIV-uninfected adults and adolescents in northern Tanzania